Many novel PET radiotracers have demonstrated potential use in breast cancer. Although not currently approved for clinical use in the breast cancer population, these innovative imaging agents may one day play a role in the diagnosis, staging, management, and even treatment of breast cancer.
Keywords: Breast cancer; FAPI; FLT; FMISO; Fluciclovine; ImmunoPET; PARP; PET/CT.
Copyright © 2023 Elsevier Inc. All rights reserved.